Arginine deprivation, autophagy, apoptosis (AAA) for the treatment of melanoma.
The majority of melanoma cells do not express argininosuccinate synthetase (ASS), and hence cannot synthesize arginine from citrulline. Their growth and proliferation depend on exogenous supply of arginine. Arginine degradation using arginine deiminase (ADI) leads to growth inhibition and eventually cell death while normal cell which express ASS can survive. This notion has been translated into clinical trial. Pegylated ADI (ADI-PEG20) has shown antitumor activity in melanoma. However, the sensitivity to ADI is different among ASS(-) melanoma cells. We have investigated and reviewed the signaling pathways which are affected by arginine deprivation and their consequences which lead to cell death. We have found that arginine deprivation inhibits mTOR signaling but leads to activation of MEK and ERK with no changes in BRAF. These changes most likely lead to autophagy, a possible mechanism to survive by recycling intracellular arginine. However apoptosis does occur which can be both caspase dependent or independent In order to increase the therapeutic efficacy of this form of treatment, one should consider adding other agent(s) which can drive the cells toward apoptosis or inhibit the autophagic process.
Savaraj
N
N
VA Medical Center, Miami, FL 33125, USA. nsavaraj@med.miami.edu
You
M
M
Wu
C
C
Wangpaichitr
M
M
Kuo
M T
MT
Feun
L G
LG
D017209:Apoptosis / Q000502:physiology; D001120:Arginine / Q000037:antagonists & inhibitors* / Q000378:metabolism; D001124:Argininosuccinate Synthase / Q000378:metabolism; D001343:Autophagy / Q000502:physiology; D006801:Humans; D006867:Hydrolases / Q000627:therapeutic use; D047908:Intracellular Signaling Peptides and Proteins / Q000378:metabolism; D020935:MAP Kinase Signaling System; D008545:Melanoma / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D008954:Models, Biological; D011092:Polyethylene Glycols / Q000627:therapeutic use; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism; D015398:Signal Transduction; D058570:TOR Serine-Threonine Kinases
D047908:Intracellular Signaling Peptides and Proteins; D011092:Polyethylene Glycols; D001120:Arginine; C546842:MTOR protein, human; D017346:Protein Serine-Threonine Kinases; D058570:TOR Serine-Threonine Kinases; D006867:Hydrolases; C512527:ADI PEG20; D001124:Argininosuccinate Synthase
J Biol Chem. 2009 Aug 7;284(32):21412-24
19520853
Cell Death Differ. 2005 Nov;12 Suppl 2:1509-18
16247498
Pathol Oncol Res. 2002;8(1):18-25
11994758
Cell Death Differ. 2009 Jan;16(1):12-20
18600232
Leukemia. 2000 May;14(5):826-9
10803513
Eur J Biochem. 2003 May;270(9):1887-99
12709047
J Biol Chem. 2008 Feb 22;283(8):4766-77
18073215
Biochem Biophys Res Commun. 2004 Jan 9;313(2):429-36
14684180
Nat Cell Biol. 2004 Dec;6(12):1221-8
15558033
Nature. 1968 Aug 17;219(5155):750-2
5667076
J Biol Chem. 2003 May 9;278(19):16667-74
12609989
Pathobiology. 2001;69(3):120-6
11872957
Curr Pharm Des. 2008;14(11):1049-57
18473854
Int J Cancer. 1992 May 8;51(2):244-9
1568792
Curr Opin Oncol. 2008 Mar;20(2):183-9
18300768
Nat Rev Cancer. 2005 Sep;5(9):726-34
16148885
Expert Opin Investig Drugs. 2006 Jul;15(7):815-22
16787144
Biochem Biophys Res Commun. 2004 Jan 9;313(2):443-6
14684182
J Biol Chem. 2008 Apr 18;283(16):10892-903
18281291
Infect Immun. 1990 Aug;58(8):2510-5
2370103
Autophagy. 2009 May;5(4):567-8
19276647
J Gastroenterol Hepatol. 2007 Jan;22(1):86-91
17201887
J Cell Sci. 2000 Apr;113 ( Pt 7):1189-98
10704370
Am J Clin Nutr. 2006 Feb;83(2):508S-512S
16470022
Cell Res. 2007 Oct;17(10):839-49
17893711
Curr Opin Cell Biol. 2005 Dec;17(6):596-603
16226444
Biochem Biophys Res Commun. 2010 Apr 9;394(3):760-6
20227389
Biochimie. 2008 Feb;90(2):313-23
17928127
Proc Soc Exp Biol Med. 1966 Dec;123(3):790-5
5959021
Drug Target Insights. 2007;2:119-28
21901069
Jpn J Cancer Res. 1995 Sep;86(9):840-6
7591961
Cancer Res. 2009 Jan 15;69(2):700-8
19147587
J Clin Oncol. 2005 Oct 20;23(30):7660-8
16234528
Genes Cells. 2008 Jun;13(6):537-47
18533003
Clin Cancer Res. 2006 Dec 1;12(23):7126-31
17145837
Cancer Genet Cytogenet. 2004 Jan 1;148(1):1-6
14697634
Cancer Res. 1990 Aug 1;50(15):4522-7
2164440
Nat Rev Mol Cell Biol. 2007 Sep;8(9):741-52
17717517
Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3438-43
14993595
Cancer Res. 2007 Jan 1;67(1):309-17
17210712
Cell Death Differ. 2004 Apr;11(4):448-57
14713959
Autophagy. 2007 Jan-Feb;3(1):28-31
16969128
Med Sci Monit. 2002 Jul;8(7):BR248-53
12118186
Cancer Res. 1990 Jan 15;50(2):345-9
2403840
Mol Cancer Ther. 2009 Dec;8(12):3223-33
19934275
Nat Cell Biol. 2007 Oct;9(10):1102-9
17909521
Cancer Res. 2002 Oct 1;62(19):5443-50
12359751
J Nutr. 2004 Oct;134(10 Suppl):2837S-2841S; discussion 2853S
15465796
Mol Cell Biochem. 2003 Feb;244(1-2):177-85
12701828
Autophagy. 2007 Jul-Aug;3(4):381-3
17457036
Cell. 2005 Jan 28;120(2):237-48
15680329
Cancer Lett. 2009 May 8;277(1):91-100
19138817
J Clin Invest. 2005 Oct;115(10):2679-88
16200202
J Clin Oncol. 2004 May 15;22(10):1815-22
15143074
Leuk Res. 1990;14(10):931-4
2259230
J Clin Invest. 2007 Feb;117(2):326-36
17235397
J Biol Chem. 2005 Aug 12;280(32):29060-6
15980064
Hepatogastroenterology. 2003 Sep-Oct;50(53):1214-6
14571701
Semin Cancer Biol. 2005 Aug;15(4):247-53
15886013
Annu Rev Nutr. 2005;25:59-85
16011459